Medications for Opioid Use Disorder-Presentation

Video Transcription

Video Summary

Dr. Melissa Weimer, an Associate Professor of Medicine and Public Health at Yale University, discusses medications for opioid use disorder in a video presentation. She begins by introducing herself and her qualifications. Dr. Weimer highlights the objectives of her talk, which include understanding the rationale for using medications for opioid use disorder, describing effective medications for treating opioid use disorder, and explaining the unique properties of methadone, buprenorphine, and extended-release naltrexone.<br /><br />Dr. Weimer presents a case study of a 23-year-old female named Jane who has been using opioids for four years and wants help to stop using injection opioids. Jane has a supportive living situation and has experienced unintentional opioid overdoses in the past year. Dr. Weimer prompts the audience to consider whether medications for opioid use disorder are indicated for Jane and discusses the additional evaluation needed to decide on the most appropriate medication for her. The presentation also covers the spectrum of opioid use, the natural history of opioid use disorder, and the diagnostic criteria for opioid use disorder according to the DSM-5.<br /><br />Dr. Weimer emphasizes the importance of medication treatment for opioid use disorder in reducing mortality and associated morbidity. She discusses the common misconceptions and barriers to using opioid agonist medications, such as methadone and buprenorphine. The presentation provides an overview of the properties, indications, contraindications, precautions, and efficacy of methadone, buprenorphine, and extended-release naltrexone. Dr. Weimer highlights the need for access to these medications and discusses various models of care for treating individuals with opioid use disorder.<br /><br />The presentation concludes with a case-based discussion and suggestions for harm reduction strategies for individuals who may not be ready to stop using opioids. Dr. Weimer emphasizes the importance of maintaining a non-judgmental and supportive approach to patients and provides information on resources and references for further information.

Asset Subtitle

View the recorded presentation to attest that you have viewed the presentation in its entirety.

Keywords

opioid use disorder

medications

methadone

buprenorphine

extended-release naltrexone

case study

DSM-5

mortality

harm reduction strategies